Cargando…

The molecular mechanism underlying dermatomyositis related interstitial lung disease: evidence from bioinformatic analysis and in vivo validation

BACKGROUND: Dermatomyositis (DM) is an autoimmune and inflammatory disease that can affect the lungs, causing interstitial lung diseases (ILD). However, the exact pathophysiological mechanisms underlying DM-ILD are unknown. Idiopathic pulmonary fibrosis (IPF) belongs to the broader spectrum of ILD a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Li, Tang, Yiping, Zhang, Yichen, Yue, Li, Ma, Gang, Ye, Xumin, Yang, Lijing, Chen, Kai, Zhou, Qiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622801/ https://www.ncbi.nlm.nih.gov/pubmed/37928522 http://dx.doi.org/10.3389/fimmu.2023.1288098

Ejemplares similares

Potential common molecular mechanisms between Sjögren syndrome and inclusion body myositis: a bioinformatic analysis and in vivo validation
por: Zeng, Li, et al.
Publicado: (2023)

Adrenomedullin Expression Is Associated With the Severity and Poor Prognosis of Interstitial Lung Disease in Dermatomyositis Patients
por: Ye, Lifang, et al.
Publicado: (2022)

Rituximab in the Treatment of Interstitial Lung Diseases Related to Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis: A Systematic Review
por: He, Chenjia, et al.
Publicado: (2022)

Predictors of rapidly progressive interstitial lung disease and prognosis in Chinese patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis
por: Li, Meiqi, et al.
Publicado: (2023)

Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease
por: Gui, Xianhua, et al.
Publicado: (2022)

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
por: Zhou, Shuang, et al.
Publicado: (2022)

Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome
por: Zuo, Yu, et al.
Publicado: (2022)

Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis
por: Chen, Cuihong, et al.
Publicado: (2021)

Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort
por: Chen, Fang, et al.
Publicado: (2022)

Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis
por: Gan, Yu-Zhou, et al.
Publicado: (2020)

Bioinformatics identification and validation of biomarkers and infiltrating immune cells in endometriosis
por: Jiang, Hong, et al.
Publicado: (2022)

Mitophagy and immune infiltration in vitiligo: evidence from bioinformatics analysis
por: Luo, Lingling, et al.
Publicado: (2023)

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2022)

COVID-19 Disease and Dermatomyositis: A Mini-Review
por: Qian, Jie, et al.
Publicado: (2022)

Risk Factors and Predictive Model for Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease
por: Wang, Kai, et al.
Publicado: (2022)

Pneumatosis cystoides intestinalis in dermatomyositis: a case series report and literature review
por: Liu, Jianwen, et al.
Publicado: (2023)

Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and in vivo validation
por: Xie, Yan, et al.
Publicado: (2022)

Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren’s Syndrome
por: Li, Ning, et al.
Publicado: (2021)

Gene Biomarkers Related to Th17 Cells in Macular Edema of Diabetic Retinopathy: Cutting-Edge Comprehensive Bioinformatics Analysis and In Vivo Validation
por: Huang, Jing, et al.
Publicado: (2022)

Machine learning for screening and predicting the risk of anti-MDA5 antibody in juvenile dermatomyositis children
por: Xue, Yuan, et al.
Publicado: (2023)

Identification of Vital Hub Genes and Potential Molecular Pathways of Dermatomyositis by Bioinformatics Analysis
por: Ouyang, Xueren, et al.
Publicado: (2021)

Research progress on amyopathic dermatomyositis associated with interstitial lung disease
por: Bai, Yu, et al.
Publicado: (2020)

Tozinameran: Dermatomyositis complicated by interstitial lung disease: case report
Publicado: (2022)

Corrigendum: Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren’s Syndrome
por: Li, Ning, et al.
Publicado: (2021)

Identification of Biomarkers Associated With CD4(+) T-Cell Infiltration With Gene Coexpression Network in Dermatomyositis
por: Huang, Peng, et al.
Publicado: (2022)

Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study
por: Weng, Chenghua, et al.
Publicado: (2023)

Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer
por: Aussy, Audrey, et al.
Publicado: (2017)

Five genes as diagnostic biomarkers of dermatomyositis and their correlation with immune cell infiltration
por: Zhao, Xiaohu, et al.
Publicado: (2023)

New-onset dermatomyositis following COVID-19: A case report
por: Shimizu, Hiroshi, et al.
Publicado: (2022)

Successful treatment of thymic carcinoma with dermatomyositis and interstitial pneumonia: A case report
por: Yang, Xingguo, et al.
Publicado: (2019)

Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease
por: Li, Liubing, et al.
Publicado: (2017)

Molecular Mechanisms Underlying Intestinal Ischemia/Reperfusion Injury: Bioinformatics Analysis and In Vivo Validation
por: Chen, Fengshou, et al.
Publicado: (2020)

Leveraging Genomic and Bioinformatic Analysis to Enhance Drug Repositioning for Dermatomyositis
por: Irham, Lalu Muhammad, et al.
Publicado: (2023)

Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation
por: Zhao, Tingting, et al.
Publicado: (2023)

Roles of biomarkers in anti‐MDA5‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
por: Li, Xiaomeng, et al.
Publicado: (2022)

Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools
por: Wienke, Judith, et al.
Publicado: (2018)

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
por: Nombel, Anaïs, et al.
Publicado: (2021)

Limitations to the 6-Minute Walk Test in Dermatomyositis with Interstitial Lung Disease in Comparison with Idiopathic Interstitial Pneumonia
por: Someya, Fujiko, et al.
Publicado: (2013)

Integrated bioinformatic analysis and experimental validation for exploring the key molecular of brain inflammaging
por: Du, Zhixin, et al.
Publicado: (2023)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mu956kkqdiqa2f13l68rmuesq2